CDK4, CDK6/cyclin-D1 Complex Inhibition and Radiotherapy for Cancer Control: A Role for Autophagy
The expanding clinical application of CDK4- and CDK6-inhibiting drugs in the managements of breast cancer has raised a great interest in testing these drugs in other neoplasms. The potential of combining these drugs with other therapeutic approaches seems to be an interesting work-ground to explore....
Main Authors: | Valerio Nardone, Marcella Barbarino, Antonio Angrisani, Pierpaolo Correale, Pierpaolo Pastina, Salvatore Cappabianca, Alfonso Reginelli, Luciano Mutti, Clelia Miracco, Rocco Giannicola, Antonio Giordano, Luigi Pirtoli |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/16/8391 |
Similar Items
-
Structural insights into the functional diversity of the CDK–cyclin family
by: Daniel J. Wood, et al.
Published: (2018-09-01) -
Functional characterization of the human Cdk10/Cyclin Q complex
by: Robert Düster, et al.
Published: (2022-03-01) -
Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development–Review
by: Paweł Łukasik, et al.
Published: (2021-03-01) -
Cyclin K goes with Cdk12 and Cdk13
by: Kohoutek Jiri, et al.
Published: (2012-04-01) -
Cytomegalovirus cyclin-dependent kinase ortholog vCDK/pUL97 undergoes regulatory interaction with human cyclin H and CDK7 to codetermine viral replication efficiency
by: Martin Schütz, et al.
Published: (2023-10-01)